FGP
REPL icon

Freestone Grove Partners’s Replimune Group REPL Stock Holding History

Freestone Grove Partners’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,589
Closed -$140K – 757
2024
Q4 		$140K Buy
+11,589
New +$141K ﹤0.01% 550

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Freestone Grove Partners's REPL Position: Q1 2025 in Review

Freestone Grove Partners sold out of Replimune Group (REPL) in Q1 2025, closing a stake of 11,589 shares — an estimated $140K sold.

Freestone Grove Partners first reported a position in REPL in Q4 2024 and held it in 1 quarter. The position peaked at $140K in Q4 2024. 167 funds tracked by Wall St. Rank hold REPL as of Q1 2025.

  • Freestone Grove Partners reported no remaining Replimune Group position as of Q1 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 11,589 Replimune Group shares in Q1 2025, an estimated $140K.
  • Freestone Grove Partners first reported a position in Replimune Group in Q4 2024 and held it in 1 quarter.
  • Freestone Grove Partners's Replimune Group position peaked at $140K in Q4 2024.
  • 167 funds tracked by Wall St. Rank held Replimune Group as of Q1 2025.

Based on Freestone Grove Partners's 13F filing for Q1 2025, filed 15 May 2025.